SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-16-015681
Filing Date
2016-05-31
Accepted
2016-05-31 16:33:34
Documents
1
Period of Report
2016-05-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1601438_x7-uprichard.html 4  
1 OWNERSHIP DOCUMENT t1601438_x7-uprichard.xml 4 3964
  Complete submission text file 0001571049-16-015681.txt   5447
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 161686310